Pharvaris Reports Third Quarter 2022 Financial Results and Provides Business Update
Pharvaris N.V.Announced positive top-line data for RAPIDe-1, a global Phase 2 study of PHVS416 for the on-demand treatment of HAE...
Read morePharvaris N.V.Announced positive top-line data for RAPIDe-1, a global Phase 2 study of PHVS416 for the on-demand treatment of HAE...
Read more
